Cisplatin-Induced Ototoxicity in Children and Adolescents: From Risk Recognition to Hearing Preservation
Instructor
About This Course
Cisplatin-Induced Ototoxicity in Children and Adolescents:
From Risk Recognition to Hearing Preservation
Protecting Hearing. Optimizing Cancer Care. Improving Long-Term Outcomes.
Webinar Overview
Cisplatin remains a cornerstone treatment in pediatric and adolescent oncology, yet treatment-related hearing loss continues to be one of its most significant long-term adverse effects.
Early recognition of risk factors, timely audiological monitoring, and evidence-based hearing preservation strategies are essential to improving quality of life and long-term outcomes for young cancer survivors.
This expert-led webinar brings together leading specialists in pediatric oncology, audiology, and supportive care to discuss the latest clinical evidence, practical challenges, and multidisciplinary strategies for preventing and managing cisplatin-induced ototoxicity.
Who Should Attend?
Healthcare professionals involved in cancer care, hearing assessment, and supportive therapy.
Learning Outcomes
- Recognize the mechanisms and risk factors associated with cisplatin-induced ototoxicity.
- Understand the audiological impact of hearing loss in children and adolescents receiving cancer treatment.
- Review current clinical evidence supporting hearing preservation strategies.
- Apply best practices for monitoring and early detection of treatment-related hearing impairment.
- Explore practical considerations for multidisciplinary management and patient counseling.
- Discuss unmet clinical needs in adolescents treated with cisplatin-based regimens.
- Translate evidence into daily oncology practice through real-world case discussions.
Why Enroll?
- Gain practical insights from international and regional experts.
- Stay updated on emerging evidence and hearing preservation approaches.
- Improve multidisciplinary collaboration between oncology and audiology teams.
- Learn through interactive discussions and real clinical scenarios.
- Earn 2 CME/CPD accredited hours.
- Receive a Certificate of Attendance.
Webinar Agenda
| Time | Lecture | Speaker |
|---|---|---|
| 02:00–02:05 | Welcome, Introduction, and Meeting Objectives | Dr. Omar Salem Alsharif |
| 02:05–02:25 | Cisplatin-Induced Ototoxicity: Mechanisms, Risk Factors and Audiological Impact | Dr. Kaukab Rajput |
| 02:25–02:55 | Clinical Evidence and Practical Considerations for Hearing Preservation in Pediatric Patients | Dr. Amani Abdulrahman Al-Kofide |
| 02:55–03:15 | Cisplatin-Based Therapy in Adolescents Aged 12–18 Years: Clinical Practice and Unmet Needs | Dr. Aisha Mohammad A. Alshibany |
| 03:15–03:35 | Interactive Case Discussion | Dr. Yasser E. Elborai |
| 03:35–03:55 | Q&A Session | All Speakers |
Meet the Speakers
Protect Hearing. Improve Long-Term Outcomes.
Join leading experts for this focused, accredited live educational webinar.
Curriculum Overview
This course includes 1 modules, 1 lessons, and 2:00 hours of materials.
Cisplatin-Induced Ototoxicity in Children and Adolescents: From Risk Recognition to Hearing Preservation
Course Certificate
Certificates
Enroll in this course to start earning its certificates.
Course Specifications
Reply to Comment